Related Experiment Video
Updated: Jan 18, 2026

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
Published on: June 5, 2020
A core physiologically based toxicokinetic (PBTK) model for exposure assessment of multiple environmental phenols
Jeong Weon Choi1, Seungho Lee2, Jangwoo Lee3
1Department of Environmental Science, Baylor University, Waco, TX, USA.
Abstract:
Environmental phenols are widely used in consumer products and are of increasing concern due to their potential endocrine-disrupting effects. Physiologically based toxicokinetic (PBTK) models offer a powerful tool for estimating human exposure by translating biomonitoring data into external intake values. However, conventional PBTK models are typically chemical-specific and resource-intensive. In this study, we developed a core human PBTK model capable of describing the absorption, distribution, metabolism, and excretion (ADME) of four groups of environmental phenols-parabens (MeP, EtP, PrP), bisphenols (BPA, BPS), triclosan (TCS), and benzophenone-3 (BP-3)-based on shared toxicokinetic characteristics. The model was calibrated and validated using human volunteer data and applied to urinary biomonitoring data from 3787 Korean adults in the Korean National Environmental Health Survey (KoNEHS 2015-2017). Estimated daily intakes (EDIs) for MeP, EtP, PrP, and BPA were estimated via reverse dosimetry and compared with values derived from the conventional fractional urinary excretion (Fue) method. Median EDIs derived from the PBTK model were 3.7, 4.8, 0.4, and 0.02 μg/kg-bw/day for MeP, EtP, PrP, and BPA, respectively, and showed good agreement with Fue based estimates. The core model successfully captured blood and urinary concentration profiles across multiple phenols, demonstrating its potential as a practical and scalable framework for exposure assessment. Furthermore, the model was used in a reverse dosimetry framework to estimate human exposure levels from urinary biomonitoring data. This approach can be particularly valuable when chemical-specific models are unavailable, offering an efficient alternative for interpreting biomonitoring data in environmental health risk assessment.
More Related Videos
05:47In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
08:22Author Spotlight: A New and Efficient Method for Comprehensive Metabolite Cytotoxicity Assessment of Triazole Pesticides in Plants
Published on: December 22, 2023
Related Concept Videos
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Model Approaches for Pharmacokinetic Data: Physiological Models
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...